FMC Corp

FMC Corp (FMC) Stock Analysis

$5.310

-0.049 (-0.93%)At close

Loading chart…
High
5.505
Open
5.400
VWAP
5.37
Volume
9.14M
Mkt Cap
7.12B
Low
5.285
Amount
49.06M
EV/EBITDA, TTM
6.90

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.

AI analysis of FMC Corp (FMC)

Sell

FMC Corp is not a good buy right now due to significant financial challenges and a drastically lowered revenue outlook. The current price is $5.66, which is down 32.22% over the last 5 days, and the company has cut its Q3 revenue forecast to between $65 million and $125 million, far below previous estimates of $840 million to $900 million. Additionally, the RSI is at a very low 6.87, indicating extreme oversold conditions, but this does not negate the severe risks associated with the stock. The main risk is the anticipated adjusted EBITDA loss of $510 million to $565 million, which highlights the company's ongoing struggles with demand and inventory management.

Analyst Ratings (21)

+259.32% upside
Buy
13 Buy
8 Hold
0 Sell
Current: 5.31
Low
13.00
Average
19.08
High
28.00

BMO Capital

2026-10-06

Price Target

$11

Market Perform

UBS

2026-10-05

Price Target

$10

Neutral

Seaport Research

2026-08-04

Price Target

$21

Buy

RBC Capital

2026-08-03

Price Target

$11

Sector Perform

Morgan Stanley

2026-07-31

Price Target

$12

Equal Weight

Valuation Metrics

The current forward P/E ratio for FMC Corp (FMC) is 5.66, compared to its 5-year average forward P/E of 14.24.

Forward P/E

Undervalued
5Y Average P/E
14.24
Current P/E
5.66
Overvalued
20.02
Undervalued
8.47

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
2.39
Current EV/EBITDA
6.90
Overvalued
45.65
Undervalued
-40.88

Forward P/S

Undervalued
5Y Average P/S
1.72
Current P/S
0.24
Overvalued
2.61
Undervalued
0.84

Alphio AI Price Scenarios for FMC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%FMC

$44.59

Scenario price

B

Base

Base · 50%FMC

$42.71

Scenario price

B

Bear

Bear · 25%FMC

$40.23

Scenario price

Whales holding FMC

H

HBK Investments L.P.

+ HoldingFMC

-1.40%

3M Return

Events Timeline

2026-10-15 (ET)

16:30:00

Dow Rises 556.21 Points, Nasdaq Ends Little Changed

12:30:00

Nasdaq Underperforms as Producer Price Index Rises 1.3% MoM

10:30:00

RBC Cuts FMC Q3 EBITDA Guidance to $538M

09:30:00

Tech Stocks Decline, Nasdaq and S&P 500 Suffer Major Drops

08:00:00

FMC Cuts Q3 Guidance, Stock Down 28% to $5.85

News

FMC FAQ — answered by Alphio AI

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).

FMC Corp is not a good buy right now due to significant financial challenges and a drastically lowered revenue outlook. The current price is $5.66, which is down 32.22% over the last 5 days, and the company has cut its Q3 revenue forecast to between $65 million and $125 million, far below previous estimates of $840 million to $900 million. Additionally, the RSI is at a very low 6.87, indicating extreme oversold conditions, but this does not negate the severe risks associated with the stock. The main risk is the anticipated adjusted EBITDA loss of $510 million to $565 million, which highlights the company's ongoing struggles with demand and inventory management.

21 analysts cover FMC: 13 rate it Buy, 8 Hold and 0 Sell. The average price target is 19.08.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading